ANXA10 Polyclonal antibody

ANXA10 Polyclonal Antibody for WB, IHC, ELISA
Cat No. 27783-1-AP

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IHC, ELISA

Annexin A10, Annexin 10, Annexin 14, ANX10, ANX14

Formulation:  PBS and Azide
PBS and Azide
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive WB detected inmouse stomach tissue, rat stomach tissue
Positive IHC detected inrat stomach tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:2000-1:12000
Immunohistochemistry (IHC)IHC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

27783-1-AP targets ANXA10 in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen ANXA10 fusion protein Ag27094 Predict reactive species
Full Name annexin A10
Calculated Molecular Weight 37 kDa
Observed Molecular Weight 30 kDa
GenBank Accession NumberBC007320
Gene Symbol ANXA10
Gene ID (NCBI) 11199
RRIDAB_3669622
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
UNIPROT IDQ9UJ72
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

ANXA10 (annexin A10) is a member of the annexin family, and its biological effects are mediated primarily through the calcium-dependent phospholipid-binding and calcium ion binding. ANXA10 is frequently found to be highly expressed in human oral cancer, and this high expression may promote G1 phase cell cycle progression by activating the ERK/MAPK signalling pathway, which in turn results in the reduced expression of member-dependent kinases of cell cycle proteinsn and proliferation. While ANXA10 plays a diverse role in different tumours, in hepatocellular carcinoma, the overexpression of ANXA10 significantly promotes apoptosis. Conversely, in papillary thyroid cancer, the knockdown of ANXA10 promotes apoptosis by inhibiting the MAPK/ERK signalling pathway through the downregulation of TSG101 (PMID: 36936694).

Protocols

Product Specific Protocols
WB protocol for ANXA10 antibody 27783-1-APDownload protocol
IHC protocol for ANXA10 antibody 27783-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...